Teen alcohol consumption tied to benign breast disease

Share this article:
Teen Alcohol Consumption Tied to Benign Breast Disease
Teen Alcohol Consumption Tied to Benign Breast Disease

MONDAY, April 9 (HealthDay News) -- Adolescent alcohol consumption is associated with increased risk of proliferative benign breast disease (BBD), which is a risk factor for breast cancer, and there is no evidence that adolescent folate intake provides a protective effect against alcohol-associated BBD, according to a study published online April 9 in Pediatrics.

Ying Liu, M.D., Ph.D., of the Washington University School of Medicine in St. Louis, and colleagues analyzed data from 29,117 women in the Nurses' Health Study II who completed both adolescent alcohol consumption questions in 1989 and an adolescent diet questionnaire in 1998. A total of 659 women with proliferative BBD diagnosed between 1991 and 2001 were confirmed by central pathology review.

The researchers found that adolescent alcohol consumption was dose-dependently associated with an increased risk of proliferative BBD (hazard ratio, 1.15 per 10 g/day consumption; 95 percent confidence interval, 1.03 to 1.28). No significant association was observed between adolescent folate intake and the risk of proliferative BBD. Each 10 g/day increment of alcohol intake during adolescence was associated with a 21 percent increase in the risk of proliferative BBD among women with low folate intake during adolescence. This number was not significantly different from the alcohol-associated risk among women with moderate and high folate intake during adolescence.

"Adolescent alcohol consumption is associated with increased risk of proliferative BBD, which may not be reduced by increased folate intake during adolescence," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

70-Gene signature not likely to be cost-effective for breast cancer

70-Gene signature not likely to be cost-effective for ...

Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.

Many clinicians feel mobile apps can improve patient outcomes

Many clinicians feel mobile apps can improve patient ...

Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

Overdetection of PSA recurrence after radical prostatectomy more ...

For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.